Kaitlyn Wood, OTR/L in Stanleytown, VA - Occupational Therapist

Kaitlyn Wood, OTR/L is a Occupational Therapist based in Stanleytown, Virginia. Kaitlyn Wood is licensed to practice in Virginia (license number 0119008472) and her current practice location is 935 Fairystone Park Hwy, Stanleytown, Virginia. She can be reached at her office (for appointments etc.) via phone at (276) 622-3636.

NPI number for Kaitlyn Wood is 1417589961 and her current mailing address is Po Box 208, Bassett, Virginia. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1417589961.

Contact Information

	Kaitlyn Wood, OTR/L
	935 Fairystone Park Hwy, Stanleytown, VA 24168-3014
	(276) 622-3636
	(276) 627-0060

Healthcare Provider's Profile

Full Name	Kaitlyn Wood
Gender	Female
Speciality	Occupational Therapist
Location	935 Fairystone Park Hwy, Stanleytown, Virginia
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1417589961
Provider Enumeration Date: 02/12/2020
Last Update Date: 02/12/2020

Medical Identifiers

Medical identifiers for Kaitlyn Wood such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1417589961	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	0119008472 (Virginia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kaitlyn Wood is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kaitlyn Wood, OTR/L Po Box 208, Bassett, VA 24055-0208 Ph: (276) 622-3636	Kaitlyn Wood, OTR/L 935 Fairystone Park Hwy, Stanleytown, VA 24168-3014 Ph: (276) 622-3636

News Archive

Fetal health affected by mother's diet

In the United States, there has been a recent dramatic rise in the number of children classified as obese and diagnosed with obesity-related diseases, such as type 2 diabetes and nonalcoholic fatty liver disease (NAFLD).

SUVs pose greater injury risk to pedestrians

Although pedestrian injuries have decreased in recent years, they still remain a significant health problem, accounting for 13 percent of traffic fatalities in the U.S. The growing popularity of light trucks, a category that includes sport utility vehicles (SUVs), has presented a new challenge for pedestrians and raises an important question: Do light trucks increase the risk of severe injury and death for pedestrians?

Protalix BioTherapeutics commences clinical trial of human acetylcholinesterase for biodefense indications

Protalix BioTherapeutics, Inc. announced today that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers.

Vetter signs preferred partnership agreement with Sentry BioPharma Services

Vetter, a leading provider of aseptic pre-filled drug-delivery systems, and Sentry BioPharma Services, a provider of supply chain management and clinical packaging services, today announced that they have signed a preferred partnership agreement.

BioLight seeks FDA IND approval for subconjunctival Latanoprost controlled release insert Phase I/IIa study

BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that ViSci, its wholly owned subsidiary, has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to conduct a Phase I/IIa clinical study with its subconjunctival Latanoprost controlled release insert for the treatment of glaucoma.

Occupational Therapist in Stanleytown, VA

Mr. Mark O Okafor, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 935 Fairystone Park Hwy, Stanleytown, VA 24168 Phone: 276-622-3636 Fax: 888-724-0268
Heather Naff, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 935 Fairystone Park Hwy, Stanleytown, VA 24168 Phone: 276-622-3636
Journie Barbour, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 935 Fairystone Park Hwy, Stanleytown, VA 24168 Phone: 276-622-3636 Fax: 276-627-0060
Erin Lanigan, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 935 Fairystone Park Hwy, Stanleytown, VA 24168 Phone: 276-622-3636

Kaitlyn Wood, OTR/L - Occupational Therapist in Stanleytown, VA